MCL Featured Stories
PACE/State of FL - This webinar will provide an overview of recent regulatory changes impacting clinical laboratories. This will include the latest updates to Clinical Laboratory Improvement Amendments (CLIA) memos and brochures, the termination of Clinical Laboratory Improvement Advisory Committee (CLIAC) and its impact to clinical laboratories, a summary of the FDA LDT final rule regulatory journey, and a discussion of the shift to announced inspections.
Practical guidance on when and how to test yeast isolates, key susceptibility testing methods and criteria, and the role of epidemiological cutoff values (ECVs).
Mary Jo Williamson, chief administrative officer of Mayo Clinic Laboratories, shares four critical steps for successful healthcare collaborations.
In the second quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.
The laboratory test catalog is no longer just a reference list — it’s a strategic asset. By expanding its content, laboratories can improve satisfaction and experience.
After mysterious neurological symptoms began in 2010, Brad Karon, M.D., Ph.D., was diagnosed with paraneoplastic syndrome, a rare condition that led to groundbreaking research and test development at Mayo Clinic. Years later, pulmonary fibrosis and a double lung transplant would test him once again — and redefine his resilience.
This episode marks the end of “Lab Medicine Rounds.” Host Justin Kreuter, M.D., reflects on the impact of the series and introduces an upcoming video-based[...]
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss summertime illnesses and key insights from a recent diagnostic investment event.
Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC, explain how Mayo Clinic Laboratories' expanded test panel captures rarer as well as more common genetic causes of hereditary pancreatitis. That information is key to managing patients' enhanced risk for pancreatic cancer.
PACE/State of FL - Presentation Recording Coming Soon - This presentation explores the distinctions between capillary and venous collection and compares home-based versus clinic-based sampling, with attention to delayed processing and shipping stability.
Clinically relevant overview of key genetic factors, testing strategies, and post-result care.
Conflict is a natural part of human interaction, and the workplace is not immune from that experience. Through this microlearning, we'll explore how proper conflict[...]
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, share insights from industry news and recent conferences, including PlatforMed.